Quantum Biopharma (QNTM) Intangibles (2019 - 2026)
Quantum Biopharma (QNTM) posted Intangibles of $4.4 million for Q1 2026, down 2.3% sequentially from $4.5 million in Q4 2025, and down 8.71% YoY from $4.8 million in Q1 2025.
Quantum Biopharma (QNTM) Intangibles (2019 - 2026) Analysis & Trends
Quantum Biopharma has reported Intangibles for 8 years, with the latest figure at $4.4 million in Q1 2026.
- Quarterly Intangibles fell 8.71% year-over-year to $4.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.4 million (down 8.71% YoY) and the FY2025 annual result came in at $4.5 million, down 8.53% from the prior year.
- Intangibles declined to $4.4 million in Q1 2026 per QNTM's latest filing, from $4.5 million in the prior quarter.
- Over five years, Intangibles peaked at $15.4 million in Q1 2022 and troughed at $4.4 million in Q1 2026.
- A 5-year average of $7.6 million and a median of $5.1 million in 2024 frame the typical range for Intangibles.
- The sharpest annual moves came in 2022 and 2023: Intangibles climbed 19.01% in 2022, then tumbled 60.98% in 2023.
- Over 5 years, Intangibles stood at $12.0 million in 2022, then slumped by 54.64% to $5.5 million in 2023, then declined by 9.66% to $4.9 million in 2024, then retreated by 8.53% to $4.5 million in 2025, then fell by 2.3% to $4.4 million in 2026.
- According to Business Quant data, Intangibles over the past three periods registered $4.4 million, $4.5 million, and $4.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 412.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.31 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 266.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 60.96 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 93.49 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Quantum Biopharma | 15.44 Mn | 11.80 Mn | - | 4.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.30 Mn |
| Mar 31, 2026 | 4.41 Mn |
| Dec 31, 2025 | 4.51 Mn |
| Sep 30, 2025 | 4.62 Mn |
| Jun 30, 2025 | 4.73 Mn |
| Mar 31, 2025 | 4.83 Mn |
| Dec 31, 2024 | 4.93 Mn |
| Sep 30, 2024 | 5.04 Mn |
| Jun 30, 2024 | 5.15 Mn |
| Sep 30, 2023 | 5.46 Mn |
| Jun 30, 2023 | 5.57 Mn |
| Mar 31, 2023 | 10.47 Mn |
| Dec 31, 2022 | 12.04 Mn |
| Sep 30, 2022 | 13.16 Mn |
| Jun 30, 2022 | 14.27 Mn |
| Mar 31, 2022 | 15.38 Mn |
| Dec 31, 2021 | 16.20 Mn |
| Sep 30, 2021 | 17.30 Mn |
| Jun 30, 2021 | 11.99 Mn |
| Mar 31, 2021 | 12.97 Mn |